Top Tech Companies in NYC, NY (10,000+)

Strong Revenue Growth: Multi‑year revenue gains are documented through repeated Inc. 5000 recognition and company‑reported growth over recent periods, indicating sustained top‑line momentum. Public materials consistently position revenue expansion alongside broader network scale increases.

Market Expansion: The network footprint has scaled quickly in stores, screens, and shopper reach, with continued additions of retailers and locations across the U.S. Announcements highlight step‑ups from earlier milestones to a materially larger national presence.

Strong Market Position & Advantage: The platform is frequently characterized as the largest in‑store retail media network for U.S. grocery, suggesting a scale advantage across banners and geographies. Third‑party trade coverage and company materials align on leadership by store and screen footprint.

Strong Revenue Growth: Net revenue increased year over year in the latest full year, with organic sales also up, and subsequent quarterly updates continued to show growth. Emerging markets contributed more than developed markets, helping sustain the top line.

Healthy Cash Flow: The company consistently generates multi‑billion‑dollar free cash flow and has continued dividends and share repurchases. This supports financial flexibility to invest and return capital despite cost headwinds.

Strong Market Position & Advantage: The business holds leadership positions in core categories (global leader in biscuits and a top‑two player in chocolate) backed by iconic brands and worldwide reach. Such scale and category strength support resilience across regions and channels.

Investor Backing & Capital Strength: Funding progression includes a reported Series A in 2023 and total capital in the mid‑teens of millions, indicating resources to scale operations and product. Named institutional investors and multiple rounds point to continued capacity to support growth initiatives.

Market Expansion: Positioning has broadened from forestry robotics into AI‑powered field operations for utilities, including vegetation management, asset inspection, construction, and disaster response. This shift suggests access to larger, higher‑value commercial segments.

Product Line Growth: Activity logs cite next‑generation backpack and vehicle hardware shipments, faster data processing, expanded species identification, and a desktop review application. These updates indicate ongoing investment in capabilities aligned to real‑world utility workflows.

Strong Revenue Growth: Repeated inclusion on the Inc. 5000 list and an Inc. profile noting 27% three-year growth for 2026 indicate sustained top-line expansion.

Market Expansion: Acquisitions in 2023 (ABA Therapy Billing & Insurance Services) and 2025 (Joshin), plus the addition of a Chief Revenue Officer and an SVP of Enterprise Sales, point to expansion across providers, disability support, and enterprise channels.

Innovation-Driven Growth: New AI-enabled capabilities for behavioral-health workflows and analytics recognition suggest product momentum that supports continued scaling.

Strong Revenue Growth: Recent results show operating revenue rising at double‑digit rates across FY2025 and FY2026, with annualized recurring revenue increasing even faster. Growth is supported by both subscriber additions and higher average revenue per customer.

Healthy Cash Flow: Free cash flow increased year over year, indicating stronger cash generation alongside expansion. Reported figures highlight rising cash metrics even as the company scales investments.

Market Expansion: International revenue and subscribers continued to grow, with substantial gains outside Australia/New Zealand and ongoing progress in the U.S. aided by product and acquisition initiatives. Regional momentum in markets like the UK and North America underscores a widening footprint.

Product Line Growth: Product scope has widened beyond core clearing/custody, with launches such as Apex Ascend (real-time, cloud-native infrastructure), Apex Alts, and new capabilities like AI tools, prediction markets, and direct indexing, plus acquisitions including FinTron and AdvisorArch. These additions indicate a broader platform designed to serve more wealth-tech workflows and asset types.

Strategic Partnerships: Recent announcements highlight collaborations with major platforms and institutions, including Cash App Investing selecting Apex as a strategic clearing platform, Gemini choosing Apex for U.S. stock-trading custody/clearing, and integrations/alliances with Plaid, Google Cloud, and State Street. These relationships point to expanding distribution and external validation of the offering.

Strong Market Position & Advantage: Operating scale is substantial, with company-reported figures of hundreds of billions in assets under custody, tens of millions of accounts, and hundreds of millions of annual trades, alongside support for 200+ platforms. High-profile platform selections reinforce a durable position in digital investing infrastructure.

Market Expansion: Reported enrollments of roughly 250,000 in 2025 and a broker base exceeding 10,000 point to a rapidly widening operating footprint. AEP 2025 production metrics and tens of thousands of contracts processed further suggest the platform is scaling beyond its 2024 funding milestone.

Investor Backing & Capital Strength: A $25M Series B in January 2024, reportedly at a significant valuation step-up, underscores access to growth capital. Independent listings also record total funding in the high-$30Ms range, reinforcing external validation of capitalization.

Strong Hiring & Retention: Headcount reportedly expanded from around 40 to roughly 130 by 2025, and current postings include senior roles across revenue operations, engineering, product, and agent/customer experience. Active requisitions signal continued investment in growth infrastructure.

Strong Revenue Growth: Consistent year-over-year gains are highlighted, including 12 consecutive quarters as of late 2025. Growth was linked to adding 200+ net-new brands and increased engagement with curation offerings such as OpenXSelect.

Market Expansion: Geographic reach broadened with TV by OpenX entering seven additional international markets in 2024 and a new Mexico office launching LATAM expansion in 2025. Additional investment in publisher-development personnel in January 2026 is described as supporting the next phase of publisher growth.

Innovation-Driven Growth: New offerings like OpenXSelect and AI/ML capabilities via OpenX IQ, alongside advances in CTV, are positioned as commercial drivers. A post-launch uplift in monetized impressions for TV by OpenX and ongoing product rollouts signal traction.

Strong Market Position & Advantage: Platform activity and share are rising faster than TRACE benchmarks across multiple periods, and positioning as a top‑three U.S. electronic corporate‑bond venue is repeatedly noted. Records in investment‑grade and high‑yield share plus third‑party comparisons showing scale near incumbents reinforce the advantage.

Innovation-Driven Growth: Newer protocols such as RFQ and Portfolio Trading, along with automation tools like AutoPilot and Full Self Trading, are seeing rapid adoption and driving large gains in list‑based volumes. Expanding cross‑protocol usage indicates workflows and technology are deepening engagement.

Market Expansion: Institutional participation and trader counts continue to rise, with the network broadening from roughly 920 to about 1,000 institutions and more unique bonds traded year over year. Multi‑year increases in annual notional and record 2026 ADV show the platform is extending reach and penetration.

Strong Revenue Growth: Revenue is rising at a double‑digit pace year over year, with strong 2025 expansion followed by further acceleration in early 2026 and Q2 results. Management also raised full‑year 2026 revenue outlook, signaling confidence in continued top‑line growth.

Profitability: Net income and earnings per share are increasing alongside revenue, with 2025 profits up markedly and Q2 2026 earnings advancing further. Margins strengthened as the net revenue margin improved while credit metrics such as net charge‑offs trended favorably.

Resilient & Sustainable Growth: Growth has persisted across multiple years—through 2024, 2025, and into mid‑2026—supported by rising originations and a record combined loans and finance receivables balance. Guidance calling for continued revenue and adjusted EPS growth underlines expectations for ongoing, multi‑dimensional expansion.

Product Line Growth: Product scope has expanded from 2022’s branded calls/SMS to an enterprise AI‑agent platform covering inbound support, lead qualification, scheduling, collections, bookings, SMS/chat, and AI phone agents. Frequent 2026 launches like Copilot, MCP, and observability tools further indicate ongoing expansion.

Investor Backing & Capital Strength: Capital base has strengthened with a $38.5M Series A (2022) and an additional $40M financing in 2024 to accelerate AI Phone Agents, bringing publicly announced funding to roughly $82M. These rounds provide resources to scale product and go‑to‑market efforts.

Market Expansion: Presence has widened across healthcare, financial services, insurance, education, and home services, with named enterprises such as eHealth, Wealthsimple, Mutual of Omaha Mortgage, Angi, and Guitar Center. Usage milestones rising from 250M interactions (2024) to 350M calls (2025) and 500M+ calls thereafter point to expanding reach.

Strong Revenue Growth: Revenue increased solidly year over year in both the latest quarter and the full fiscal year, with momentum characterized as robust and consistent across recent periods. Company materials indicate the expansion is driven by contributions from both existing and newly added customers.

Healthy Cash Flow: Free cash flow turned positive and rose meaningfully, alongside improvements in non-GAAP operating income. These trends indicate improving cash profitability even as GAAP profitability has yet to be reached.

Customer Loyalty & Retention: Net retention indicates expansion within existing accounts, and the cohort of larger enterprise customers has grown. Together, these signals point to durable upsell and cross-sell within the installed base.

Strong Hiring & Retention: Hiring is active and broad-based across trading, technology, and operations, including roles such as Electronic Options Trader, Trading Operations Associate, and high-frequency futures/quant positions. The firm is also recruiting for future starts (e.g., a C++ role targeting 2026 graduates for 2027), indicating continued investment in capacity.

Diversified Revenue Streams: Operations span proprietary trading, execution services, asset management, and technology, providing multiple business lines beyond pure market making. The trading group participates across equities, equity/index options, futures, ETFs, bonds, and related derivatives.

Strong Market Position & Advantage: The company is described as a leading liquidity provider in exchange-listed equity derivatives and is regularly grouped with established options market makers. A multi-office footprint in Chicago, New York, San Francisco, and London underpins this presence.

Investor Backing & Capital Strength: Assets under management are described around $2.1B, with a $400M Fund III that exceeded its target and ongoing Form D activity indicating continued fund formation. Active participation in 2024–2026 financings (e.g., IO.net, CAT Labs, OpenFX) signals ample deployable capital.

Resilient & Sustainable Growth: Continued 2025–2026 investments and recent exits are characterized as evidence of resilient and sustainable growth amid a mixed market. Portfolio companies raising about $700M of growth capital since 2022, including multiple up rounds, supports a scaling platform.

Future-Ready Strategy: The investment thesis has shifted toward AI-driven ecosystems, automation, and digital infrastructure. This adaptation aligns the firm with frontier-technology demand while maintaining active early-stage deployment.

Strong Revenue Growth: Available evidence indicates revenue scaled from roughly $800 million in 2023 to an estimated $1.2 billion annualized in 2024. The longer-term trajectory shows steady gains from 2017 onward, with scale signals like surpassing 1 billion meals delivered.

Profitability: Reporting describes more than $10 million in monthly profit, indicating a shift from pure growth to profitable scaling. This supports the view that the company can sustain operations while continuing to invest.

Market Expansion: Operations have broadened beyond DTC through personalized meal plans on Walmart.com and expansion via the Woof acquisition into canine wellness products. Continued veterinary research investment and substantial TV ad spend point to active reach and capability expansion.

Market Expansion: Operations span 19+ markets across North America, Europe, Japan, and Australia, with recent additions such as a Paris office and new roles in London. Hiring across international markets indicates continued geographic growth.

Product Line Growth: Recent launches such as Mindset Agent and the global expansion of enhanced CTV/online‑video, plus ongoing Mindset Graph/Portal and sports media development, point to active product expansion. Continuous release of advanced AI tools and platform capabilities underscores momentum.

Future-Ready Strategy: A shift to cookie‑free, AI‑driven contextual targeting aligned with tightening privacy laws, reinforced by acquisitions like JustPremium and Playground xyz, positions the company for a post‑cookie environment. Security compliance and global rollouts suggest preparation for sustained, privacy‑first growth.

Market Expansion: Platform reach indicators include 3.7M people using PartySlate in the last year and 47,000+ venues and vendors on the platform, alongside an estimated ~438K monthly visits with a strong organic search share. These signals point to a growing audience and supply footprint across markets.

Product Line Growth: New offerings such as Photo Hub, AI photo search, and PartySlate Pro show active expansion beyond a directory model into software/workflow tools for event professionals. Feature rollouts and integrations during 2025–26 indicate continued investment in the product suite.

Investor Backing & Capital Strength: Multiple financing events totaling about $12.8M, including a 2025 convertible note involving FJ Labs, demonstrate ongoing access to capital. Third‑party databases also record earlier rounds (e.g., a $5.5M round in 2020), supporting capacity to invest in growth.

Strong Revenue Growth: Annualized revenue increased from $720M in March 2025 to $1.3B by March 2026, with ARR surpassing $1B in late 2025 and continuing upward. This trajectory points to sustained top-line momentum across the period cited.

Market Expansion: Geographic reach broadened with new regulated entries across multiple regions, alongside plans to deploy over $1B in the U.S. and substantial investment in Europe. Regional performance in the Americas and EMEA also advanced meaningfully, indicating traction beyond APAC.

Investor Backing & Capital Strength: Valuation rose from $6.2B (May 2025) to $11B (June 2026) through successive large funding rounds. Independent reporting corroborated the latest financing, signaling strong capital access and external confidence.

Profitability: Company materials describe sustained annual profitability since 2023 and cash-flow positivity, pairing growth with disciplined financial health. It also reports meeting efficiency benchmarks, noting it exceeded the Rule of 40 in 2025.

Strong Revenue Growth: Disclosures point to multi-year revenue expansion with momentum described as accelerating, indicating robust top-line performance. This growth is presented alongside expanding provider and patient scale.

Strategic Partnerships: The platform is increasingly embedded across external channels through integrations with Healthgrades, Yelp, Google Gemini, and payer portals, broadening distribution and demand capture. These arrangements signal deeper ecosystem reach beyond the core marketplace.

Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.

Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.

Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.